1. Home
  2. CLW vs CCCC Comparison

CLW vs CCCC Comparison

Compare CLW & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clearwater Paper Corporation

CLW

Clearwater Paper Corporation

HOLD

Current Price

$14.79

Market Cap

210.3M

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.81

Market Cap

185.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLW
CCCC
Founded
1926
2015
Country
United States
United States
Employees
3710
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
210.3M
185.1M
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
CLW
CCCC
Price
$14.79
$2.81
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$23.00
$12.20
AVG Volume (30 Days)
188.6K
2.0M
Earning Date
04-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.45
EPS
N/A
N/A
Revenue
$1,555,400,000.00
$35,947,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.42
1.02
52 Week Low
$12.46
$1.09
52 Week High
$30.96
$3.82

Technical Indicators

Market Signals
Indicator
CLW
CCCC
Relative Strength Index (RSI) 55.16 55.61
Support Level $12.46 $2.26
Resistance Level $18.85 $2.85
Average True Range (ATR) 0.67 0.20
MACD 0.28 -0.02
Stochastic Oscillator 91.95 90.43

Price Performance

Historical Comparison
CLW
CCCC

About CLW Clearwater Paper Corporation

Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: